Related Experiment Video
Updated: Mar 25, 2026

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
Characterization of additional vitamin D binding protein variants
Lei Fu1, Chad R Borges2, Douglas S Rehder2
1Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
This study identified rare genetic mutations in the vitamin D binding protein (DBP) gene. Molecular screening and mass spectrometry revealed novel mutant DBP proteins circulating in serum, confirming previously suspected deleterious variants.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- The vitamin D binding protein (DBP) gene (GC) exhibits significant genetic variation.
- Common polymorphisms like p.D432E and p.T436K may affect vitamin D metabolism.
- Previous biochemical studies suggested the existence of less common, deleterious DBP variants.
Purpose of the Study:
- To identify underlying mutations in the GC gene responsible for previously observed biochemical variants.
- To characterize the identified mutant DBP proteins using mass spectrometry.
- To confirm the presence and nature of low-frequency DBP mutations in circulation.
Main Methods:
- Genetic screening of GC exons and boundaries using denaturing high-performance liquid chromatography (DHPLC).
- Sanger sequencing to identify specific mutations.
- Immuno-capture coupled with mass spectrometry to characterize protein variants in serum.
Main Results:
- Identified an alanine deletion at codon 246 (p.A246del) in 10 samples and a cysteine to phenylalanine substitution at codon 311 (p.C311F) in 1 sample.
- Mass spectrometry confirmed the presence of mutant DBP proteins and their post-translational modifications.
- Characterized the loss of a disulfide bond at cysteine-311 and formation of a novel mixed disulfide species.
Conclusions:
- Confirms the existence of additional deleterious GC mutations, including low-frequency variants.
- Demonstrates that mutant DBP proteins are secreted and detectable in the bloodstream.
- Highlights the utility of combining molecular screening with mass spectrometry for identifying and characterizing mutant DBP species.
More Related Videos
Related Concept Videos
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Drug Distribution: Plasma Protein Binding

